Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2026-01-21 @ 3:56 PM
Study NCT ID:
NCT06526793
Status:
RECRUITING
Last Update Posted:
2025-12-11
First Post:
2024-07-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-11-27
Start Date Type:
ACTUAL
Primary Completion Date:
2027-03-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-06-14
Completion Date Type:
ESTIMATED
First Submit Date:
2024-07-03
First Submit QC Date:
None
Study First Post Date:
2024-07-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-05
Last Update Post Date:
2025-12-11
Last Update Post Date Type:
ESTIMATED